Subclinical thyroid disease

Česká verzia

Authors: Václav Zamrazil ^1,2
Authors place of work: Endokrinologický ústav Praha, ředitelka doc. RNDr. Běla Bendlová, CSc. ¹; Subkatedra endokrinologie IPVZ Praha, vedoucí subkatedry prof. MUDr. Václav Zamrazil, DrSc. ²
Published in the journal: Vnitř Lék 2015; 61(10): 873-876
Category: Reviews

Summary

Importance of subclinical thyroid disease (STh) is now a matter of discussion. Definition of this unit is laboratory: in presence of normal level of thyroxine (T₄) TSH value is changed: in lower TSH level the subclinical hyperthyroidism (STx) in increase TSH levels subclinical hypothyroidism (SH) is present. Risk of clinical manifestation is twoo three times highter in comparison with persons with normal TSH level. Clinical importance STh is still not evaluated definitively. SH caused disturbance of lipid metabolism, elasticity of vessels and endothelial function and therefore increases risk of atherosclerosis. STx causes electrical instability of myocardium with increased risk of arythmias, increases risk of osteoporosis and other changes. Most important are effects of STh in cardiology, reproductive medicine and gynecology. Clinical significance of these effects is not definitively evaluated.

Key words:
atherosclerosis – gynecology risks – hyperthyroidism – hypothyroidism – pregnancy risks – subclinical thyroid disease

Zdroje

1. Dvořáková M1, Hill M, Čerovská J et al. Vliv saturace jodem na výskyt tyreopatií ve vybraných regionech u dospělé populace České republiky. Vnitř Lék 2010; 56(12): 1262–1270.

2. Zimmermann MB, Andersson M. Assessment of iodine nutrition in populations: past, present, and future. Nutr Rev 2012; 70(10): 553–570.

3. Kahaly GY, Dienes HP, Beyer J et al. Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial. Eur J Endocrinol 1998; 139(3): 290–297.

4. Pedersen IB, Knudsen N, Jorgensen T et al. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 2003; 58(1): 36–42.

5. Taylor PN, Lazarus JH. Subclinical hypothyroidism in pregnancy. What next after CATS? Thyroid Int 2014; 2: 1–16. Dostupné z WWW: <http://www.thyrolink.com/merck_serono_thyrolink/en/images/Thyroid_Inter_2_2014_NEU_WEB_tcm1553_129405.pdf?Version=>.

6. Bliddal S, Feldt-Rassmussen N. Protilátky proti tyreoidální peroxidáze jako rizikový faktor v těhotenství. Thyroid Int (české vydání) 2015; 3: 1–39.

7. Mammen JS, McGready J, Oxman R et al. Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. Thyroid 2015; 25(9): 979–986.

8. Zhao M, Yang T, Chen Let al. Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study. Thyroid 2015; 25(5): 485–493.

9. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29(1): 76–131.

10. Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am 2012; 96(2): 269–281.

11. Lioudaki E, Mavroeidi NG, Mikhailidis DP et al. Subclinical hypothyroidism and vascular risk: an update. Hormones (Athens) 2013; 12(4): 495–506.

12. Pearce EN. Update in lipid alteration in subclinical hypothyroidism. J Clin Endocrinol Metab 2012; 97(2): 326–333.

13. Canaris GJ, Manowitz NR, Mayor G et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160(4): 526–534.

14. Pasqualetti G, Tognini S, Polini A et al. Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab 2013; 98(6): 2256–2266.

15. Meier C, Staub JJ, Roth CB et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001; 86(10): 4860–4866.

16. Asvold BO, Bjøro T, Platou C et al. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway. Clin Endocrinol (Oxf) 2012; 77(6): 911–917.

17. Liu H, Shan Z, Li C et al. Maternal subclinical hypothyroidism thyroid autoimmunity and risk of miseatiage: a prospective cohort study. Thyroid 2014; 24(11): 1642–1649.

18. Joung JY, Cho YY, Park SM et al. Effect of iodine restriction on thyroid function in subclinical hypothyroid patients in an iodine-replete area: a long period observation in a large-scale cohort. Thyroid 2014; 24(9): 1361–1368.

19. Zimmermann MB, Jooste PL, Pandav CJ. Iodine-deficiency disorders. Lancet 2008; 372(9645): 1251–1262.

20. Yoon SY, Choi SR, Kim DM et al. The effect of iodine restriction on thyroid function in patients with hypothyroidism due to Hashimoto’s thyroiditis. Yonsei Med J 2003; 44(2): 227–235.

21. Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol 2014; 10(3): 136–142.

22. Rassoly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunolog Immunopathol 1996; 81(3): 287–292.

23. Maor E, Kivity S, Kopal E et al. Differences in heart rate profile during exercice among subjects with subclinical thyroid disease. Thyroid 2013; 23(10): 1226–1232.

24. Biondi B, Palmieri EA, Fazio S et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000; 85(12): 4701–4705.

25. Biondi B, Palmieri EA, Lombardi G et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137(11): 904–914.

26. Brenta G, Mutti LA, Schnitman H et al. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 2003; 91(11): 1327–1330.

27. Rosario PW, Calsolari MG. How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L? Thyroid 2013; 23(5): 562–565.

28. Giri A, Edwards TL, LeGrys VA et al. Subclinical hypothyroidism and risk for incident ischemic stroke among postmenopausal women. Thyroid 2014; 24(8): 2010–2017.

29. Lazarus J, Brown R, Daumerie C et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyr J 2014; 3(2): 76–94.

30. Stagnaro-Green A, Abalovich M, Alexander E et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21(10): 1081–1125.

31. Teng W, Shzu Z. Pregnancy and thyroid diseases in China. Thyroid 2011; 21(10): 1053–1055.

32. Haddow JE. Thyroid Study Group. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005; 106(1): 198.

33. Krassas GF, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31(5): 702–755.

34. Männistö T, Mendola P, Grewal J et al. Thyroid diseases and adverse pregnant outcomer in contemporaly US cohort. J Clin Endocrinol Metab 2013; 98(7): 2725–2733.

35. Wilson KL, Casey BM, Melutize DT et al. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstred Gynecol 2012; 119(2 Pt1): 315–320.